The scope of this review includes the multifactorial pathophysiology of parenteral nutrition–associated liver disease/intestinal failure–associated liver disease as it relates to the pharmaceutical aspects of the various lipid injectable emulsions on the market.
The study compares growth and fatty acids in extremely low birth weight infants who received 100% soybean oil emulsions or multi-oil emulsion with 15% fish oil.
This review deals with a recent literature search that provides up-to-date data over the past decade.
This review deals with a recent literature search which provides up-to-date data over the last decade.
The impact on fatty acid balance and outcomes using lipid emulsions, enteral nutrition, and enteral supplements are reviewed, including a summary of recent clinical trials of enteral fatty acid supplementation for the preterm infant.
A review of the impact on fatty acid balance and outcomes using lipid emulsions, enteral nutrition, and enteral supplements, including a summary of the most recent large clinical trials of enteral fatty acid supplementation for the preterm infant.
Part 1 of this series addressed issues associated with and safety recommendations pertaining to adult lipid injectable emulsions use. Part 2 addresses lipid injectable emulsions safety in neonatal and pediatric patients.
Safety and efficacy outcomes were evaluated in patients on home parenteral nutrition younger than 18 years treated with composite lipid emulsion.
The aim of the study was to investigate multiple parameters of the immune responses in a cohort of patients with head and neck squamous cell carcinoma undergoing supplemental parenteral nutrition with bags enriched in omega-3 or omega-9 and omega-6 fatty acids.